semifinals 1

Upload: calimlim-kim

Post on 07-Jul-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 Semifinals 1

    1/354

    NURSING CARE OF A FAMILY

    EXPERIENCING POSTPARTALCOMPLICATIONSBY: AMPE C. ASUNCION, R.N., M.A.N.

  • 8/19/2019 Semifinals 1

    2/354

    Problems with the Psyche

      Ab!"#o"me"t !tte"tio" h!s shi$te# $romthe clie"t to the b!by% $!ther m!y com&l!i"th!t the clie"t h!s "o time $or him

     

    'is!&&oi"tme"t b!by #oes "ot t(r" o(t !se)&ecte#% comme"t o" the chil#*s +oo#&oi"ts

      Post&!rt!l ,l(es -./.0 #!ys A,1 occ(rs i"

    20 3 o$ !ll births% te!r$(l"ess4 $eeli"+s o$i"!#e5(!cy4 moo# l!bility4 !"ore)i!4 !"#slee& #ist(rb!"ce% #(e to hormo"!l ch!"+es

    or stress o$ li$e ch!"+es6

  • 8/19/2019 Semifinals 1

    3/354

    Ofer support, empathy, compassionand understanding

    POSTPARTAL DEPRESSION (1-12months AB):(p. 695)Woman experiences overwhelming eeling o

    sadness, ina!ility to stop crying, increased anxietya!out her own and inant"s health, insecurity,psychosomatic symptoms, and either depressive ormanic mood #uctuations.$ssess or hx. o previous depression, hormonal

    response or lac% o social support.&rovide counselling or drug therapy'is% actors include hx o depression, trou!ledchildhood, low sel esteem, stress at homewor%,

    lac% o efective support people

  • 8/19/2019 Semifinals 1

    4/354

    POSTPARTAL PSYC7OSIS Occ(rs withi" . ye!r !$ter birth

    'el(sio"s or h!ll(ci"!tio"s o$ h!rmi"+ i"$!"tor sel$ 

    .3/83 o$ !ll births

    Possible !cti9!tio" o$ me"t!l ill"ess4 hormo"!lch!"+es4 $!mily h) o$ bi&ol!r #isor#er

    Loss o$ co"t!ct with re!lity4 wom!" m!y #e"y

    bei"+ &re+"!"t Pro9i#e &sychother!&y4 #r(+ ther!&y4 re$er to

    &sychi!tric c!re

    S!$e+(!r# mother $rom i":(ry to sel$ or to

    "ewbor"% "e9er le!9e wom!" !lo"e with chil#

  • 8/19/2019 Semifinals 1

    5/354

  • 8/19/2019 Semifinals 1

    6/354

    POSTPARTAL 7EMORR7AGE -&6;2;1

    Possible threat throughout pregnancy andimmediate postpartal period.

    Blood loss from uterus 500- 1,000 ml/24hours

    1 !arly- "rst 24 hours

    2 #ate- any time after the "rst 24 hoursduring the remaining days of the $ %ee&-

    PPP.

    ''' (auses are uterine atony, lacerations,

    retained placental fragments, uterine

  • 8/19/2019 Semifinals 1

    7/354

    Uteri"e Ato"y

      Most $re5(e"t c!(se o$ (teri"e blee#i"+

      Co"#itio"s th!t i"cre!se ris< $or PP7

    Co"#itio"s th!t c!(se O9er#iste"sio" o$(ter(s

    Co"#itio"s th!t c!(se cer9ic!l or (teri"el!cer!tio"s

    Co"#itio" o$ 9!rie# &l!ce"t!l site or

    !tt!chme"t I"!bility o$ (ter(s to co"tr!ct

    I"!#e5(!te bloo# co!+(l!tio"

  • 8/19/2019 Semifinals 1

    8/354

      N(rsi"+ #i!+"oses $or hemorrh!+e

    ='e>cie"t ?(i# 9ol(me rel!te# to e)cessi9ebloo# loss !$ter birth

    / &eri"e!l &!# s!t(r!tio" is !bo(t 8@/@0 ml

    -8@/@0+1

    NURSING INTERENTIONS

    .1Pre9e"tio" is &!l&!ti"+ the $("#(s !tre+(l!r i"ter9!ls4 sho(l# o"ly be #o"e whe"

    $("#(s is bo++y681Assess $("#ic hei+ht !"# lochi! re+(l!rly $or

    the "e)t B ho(rs

  • 8/19/2019 Semifinals 1

    9/354

    1 'il(te o)ytoci" is (s(!lly or#ere# .0/B0UD.L4 $ollowe# by 7em!b!te re&e!te# 5.@/0mi"(tes (& to #oses4 Mether+i"e4e9ery 8/

    B ho(rs (& to @ #oses6B1 Rect!l Miso&rostol is +i9e"

    @1 Oer be#&!" to em&ty bl!##er

    ;1 O)y+e" by m!s< !t B LDmi" $or res&ir!tory#istress

    21,im!"(!l com&ressio" to #etect ret!i"e#

    &l!ce"t!l $r!+me"ts1Prost!+l!"#i" !#mi"istr!tio"

    1,loo# tr!"s$(sio"

  • 8/19/2019 Semifinals 1

    10/354

    S(bi"9ol(tio"

      Occ(rs !t B/; wee

  • 8/19/2019 Semifinals 1

    11/354

  • 8/19/2019 Semifinals 1

    12/354

    *) W+- O/ &O/0&$'0$1 213/ (&&2)4OO-1 O443'7

    8) W+$0 / 0+ &'$'4$3/ O: &&27

    ;) W+- O/ &O/0&$'0$1 &/4+O//(&&&)O443'7

    -0O- :O' &&&7

    6) $O3-0 O: 21OO 1O// -&O/0&$'0$1 +O''+$=

    ?,@,9 4$3// O: &O/0&$'0$1

    +O''+$=

  • 8/19/2019 Semifinals 1

    13/354

    *A) O/0 :'B3-0 4$3/ O: 30'-21-=

    **) => O- 4$3/ O: 4'>4$1

    1$4'$0O- &O/0&$'03

    *8) => O- C$&1 O: $ &1$4-0$14O-0O-0+$0 4$- 4$3/ 21-=

    &O/0&$'03*;) &'O'0 -/= -0'>-0O- :O' &&

    +O''+$=

    *

  • 8/19/2019 Semifinals 1

    14/354

    *?)-&--0 -3'/-=-0'>-0O- 0O $ - 30'-4O-0'$40O- (-O0 $//$=)

    *@) O/ O: 0+'=- =>- :O'/32->O130O-

    *98A) 4$3// O: /32->O130O-

  • 8/19/2019 Semifinals 1

    15/354

    P(er&er!l I"$ectio" -&;81  Pro+"osis #e&e"#s o"

    ir(le"ce o$ i"9!#i"+ microbes› Hom!"*s +e"er!l he!lth

    › Port!l o$ e"try

    › 'e+ree o$ i"9ol(tio" !t time o$ i"$ectio"

    › Prese"ce o$ l!cer!tio"s i" re&ro#(cti9e tr!ct

    .1 E"#ometritis-2/.0 #!ys1 !ssoci!te# withchorio!m"io"itis !"# CS% $e9er e9i#e"t o" the r# 

    or Bth #!y% =.006B*F $or 8 co"sec(ti9e 8B ho(rs6/ Cli"#!myci"4 Mether+i"e !"# !"!l+esics !re+i9e"% !mb(l!te clie"t to #r!i" lochi!% t(b!lsc!rri"+ !"# $(t(re i"$ertility m!y occ(r i$

    ("tre!te#6

  • 8/19/2019 Semifinals 1

    16/354

    81 Ho("# i"$ectio" &!i"4 he!t !"# swelli"+ is&rese"t% $e9er m!y or m!y "ot be &rese"t6

    / s(t(re m!y be remo9e# to !llow #r!i"!+e6

    / !"tibiotics !"# !"!l+esics m!y be +i9e"

    /Sit b!th4 moist w!rm com&ress !&&lic!tio"

    /Fre5(e"t ch!"+e o$ &eri&!#s !"#

    h!"#w!shi"+ sho(l# be #o"e

    / wi&e $rom $ro"t to b!c< to !9oi# $(rtherco"t!mi"!tio"

    1 Throm&hlebitis i"?!mm!tio" with$orm!tio" o$ bloo# clots

  • 8/19/2019 Semifinals 1

    17/354

    C!(ses o$ Thrombo&hlebitis

    = i"cre!se# >bri"o+e" le9els c!(si"+i"cre!se# clotti"+

    'il!t!tio" o$ lower e)tremity 9ei"s #(e to&ress(re o$ $et!l he!#

    I"!cti9ity or (se o$ stirr(&s m!y le!# to&ooli"+4 st!sis !"# clotti"+ o$ bloo# i"e)tremities

    Obesity #(e to i"!cti9ity !"# wei+ht +!i" Ci+!rette smo

  • 8/19/2019 Semifinals 1

    18/354

    Pre9e"tio" o$ TP

    .1 Goo# !se&tic tech"i5(e

    81 E!rly !mb(l!tio"

    1 Limit stirr(&s (se !"# (se them well/&!##e#

    B1 He!r s(&&ort stocrst 8 w

  • 8/19/2019 Semifinals 1

    19/354

    N(rsi"+ I"ter9e"tio"s $or Femor!l TP

    .1Ele9!te le+ !"# (se be# cr!#le4 "o wri"

  • 8/19/2019 Semifinals 1

    20/354

  • 8/19/2019 Semifinals 1

    21/354

  • 8/19/2019 Semifinals 1

    22/354

    Pel9ic TP -&;1

    / I"9ol9es the o9!ri!"4 (teri"e or hy&o+!stric

    9ei"s !"# $ollows ! mil# e"#ometritis !"#occ(rs l!ter th!" $emor!l TP4 o$te" !ro("#the .B/.@th #!y PP6

    / clie"t e)hibits s(##e" ill"ess4 hi+h $e9er4chills4 +e"er!l m!l!ise6

    / Se9ere i"$ectio" c!" le!# to 9ei" "ecrosis!"# &el9ic !bscess

    / Systemic i"$ectio" c!" c!(se l("+4 he!rt4 or

  • 8/19/2019 Semifinals 1

    23/354

      'ise!se r("s its co(rse $or ;/ wee

  • 8/19/2019 Semifinals 1

    24/354

    Uri"!ry Tr!ct I"$ectio" -&6;81

      C!theteri!tio" i"cre!ses ris< $or #e9t o$ UTI6

      Sym&toms i"cl(#e b(r"i"+ o" (ri"!tio"4hem!t(ri!4 $re5(e"cy4 lower !b#omi"!l &!i"4low/ +r!#e $e9er6

     N(rsi"+ I"ter9e"tio"s

      Amo)icilli" or Am&icilli" is +i9e" !s or#ere# $or@/2 #!ys to com&letely er!#ic!te the i"$ectio"

      O"e +l!ss o$ w!terDhr to ?(sh o(t to)i"s

      Acet!mi"o&he" to re#(ce #ys(ri!

    " er y ( er y &

  • 8/19/2019 Semifinals 1

    25/354

    " er y ( er y &6.2.1

      Hhe" &re+"!"cy #oes "ot occ(r !$ter . ye!r o$

    ("&rotecte# se).1 Prim!ry/ "o &re9io(s co"ce&tio"s h!9e occ(rre#

    81 Seco"#!ry/ &re9io(s 9i!ble &re+"!"cy b(t co(&leis ("!ble to co"cei9e !t &rese"t

    M!le F!ctors

    I"!#e5(!te s&erm co("t -NJ 80 MDml or @0 MDe:

    @03 sho(l# be motile4 03"orm!l i" sh!&e !"#$orm

    Chro"ic i"$ectio"s li

  • 8/19/2019 Semifinals 1

    26/354

    I"cre!se# scrot!l he!t -#es< :obs4 #ri9i"+4$re5(e"t (se o$ hot t(bs1

    Co"+e"it!l !"om!lies -cry&torchi#ism or

    9!ricocele1 Im&!ire# s&erm motility #(e to obstr(ctio"s

    c!(se# by m(m&s4 orchitis4 +o"orrhe!4

    !sce"#i"+ i"$ectio"s4 9!sectomies4 hy&oDe&is&!#i!s

    Erectile #ys$("ctio"s -&rim!ry/ "e9er!chie9e# erectio" !"# e:!c(l!tio"Dseco"#!ry/&rese"t #iKc(lty i" !chie9i"+e:!c(l!tio"

    Prem!t(re e:!c(l!tio"/ "orm!l i"

    !#olesce"ts

  • 8/19/2019 Semifinals 1

    27/354

    F l F t $ S b$ tilit

  • 8/19/2019 Semifinals 1

    28/354

    Fem!le F!ctors o$ S(b$ertility

    *) $novulation  most commo" c!(se% m!y be#(e to T(r"er*s sy"#rome -hy&o+o"!#ism1 or!bse"ce o$ o9!ries% hy&othyroi#ism% o9!ri!"t(mors% e)&os(re to X/r!ys% 9!ri!tio"s i"o9(l!tory &!tter"s

    8) 0u!al transport pro!lems #(e to t(b!lsc!rri"+ #(e to !&&e"#ectomy4 !b#omi"!ls(r+ery or i"$ectio" or ,TL% PI' #(e to ST' or!$ter me"ses whe" b!cteri!l +rowth is hi+hest4

    or IU' (se;) 3terine pro!lems c!(se# by >brom!s4

    #e$ormities4 e"#ometriosis or "o#(les i"'o(+l!s* c(l/#e/s!c4 o9!ries4 (teri"e li+!me"ts4

    !"# o(ter s(r$!ces o$ (ter(s !"# bowel

  • 8/19/2019 Semifinals 1

    29/354

    B1 4ervical pro!lems c!(se# by "o"

  • 8/19/2019 Semifinals 1

    30/354

    B1 4ervical pro!lems c!(se# by "o"/sy"chro"i!tio" o$ coit(s with time o$o9(l!tio" -.8/28 ho(rs14 i"?!mm!tio" o$

    cer9i)4 obstr(ctio" or ti+hte"i"+ o$ os4m(lti&le 'C4 cer9ic!l co"i!tio"

    @1 >aginal pro!lems i"$ectio" o$ the 9!+i"!

    c!(si"+ !ci#otic &74 s&erm/ immobilii"+bloo# &l!sm!-a! 846)

    iagnostic testsD

    .1 Assessme"t o$ he!lth history/ #iet4e)ercise4 !lcohol4 #r(+4 tob!cco (se4co"+e"it!l &roblems4 #ise!ses4

    co"tr!ce&ti9e (se4 se)(!l &r!ctices4 (se o$

  • 8/19/2019 Semifinals 1

    31/354

    81 &hysical exam to r(le o(t obstr(ctio" i"

  • 8/19/2019 Semifinals 1

    32/354

    81 &hysical exam to r(le o(t obstr(ctio" i"re&ro#(cti9e t(b(les

    1 :ertility testing seme" !"!lysis4 o9(l!tio"

    mo"itori"+4 t(b!l &!te"cy !ssessme"t6A6 emen analysis/ !$ter !bsti"e"ce $or 8/B#!ys4 seme" !ssesse#4 mi"im(m is 80MDml6%re&e!te# !$ter 8/ mo"ths4 s&erm m!t(rity is

    re!che# i" 0/0 #!ys

    Norm!l @0/800 MDml

    A9er!+e e:!c(l!tio" 86@/@ ml

    ,6 )ulation monitoring/ #o"e by recor#i"+ ,,T$or B mo"ths4 tem& rise sho(l# l!st !t le!st .0#!ys% Fertel me!s(res FS7 le9els i" 0 mi"(tes

    C ubal patency (ltr!so("# !"# X r!y

  • 8/19/2019 Semifinals 1

    33/354

    C. ubal patency / (ltr!so("# !"# X/r!yim!+i"+ !re (se# to !ssess $or obstr(ctio"s

     I"ter9e"tio"s

    .1 I"cre!se s&erm co("t !"# motility by

    =!bsti"e"ce $or 2/.0 #!ys

    =li+!tio" o$ 9!ricocele

    =ch!"+es i" li$estyle - we!r looser clothi"+bo)ers i"ste!# o$ brie$s4 !9oi# &rolo"+e#sitti"+4 hot b!ths

    81 Re#(ce i"$ectio"1 7ormo"e ther!&y/ G"R74 Clomi# (se

    B1S(r+ery4 i"semi"!tio"4 i" 9itro F4 !#o&tio"4

    s(rro+!te motherhoo#4 chil#/$ree li9i"+

    N(rsi"+ C!re o$ 7i+h Ris< Newbor"

  • 8/19/2019 Semifinals 1

    34/354

    N(rsi"+ C!re o$ 7i+h/ Ris< Newbor"-&6201

    *) /$11 :O' =/0$0O- $= below the .0th 

    &erce"tile #(e to IUGR -/84@00 + or @6 o("ces1%8B/BBth wee<

    =&reterm/ below th wee< +est!tio"

    =term/ betwee" / B8 wee

  • 8/19/2019 Semifinals 1

    35/354

    Assessme"t

      'o"e by me!s(ri"+ $("#!l hei+ht4(ltr!so("#4 NST4 !m"iotic ?(i# !mo("t6%

    Ces!ri!" birth is birth metho# o$ choice6  arly deprivation #ecre!se# wei+ht4

    le"+th !"# he!# circ(m$ere"ce

      1ate deprivation re#(ce# wei+ht6  O9er!ll w!ste# !&&e!r!"ce4 &oor s

  • 8/19/2019 Semifinals 1

    36/354

    L!b >"#i"+s

  • 8/19/2019 Semifinals 1

    37/354

      L!b >"#i"+s

    = hem!tocrit #(e to l!c< o$ ?(i# i" (tero

    = R,C/ !"o)i! i"cre!ses &ro#(ctio" o$ R,C%

    c!(ses 9iscosityJ !crocy!"osis6

    ;0/203 / hem!tocrit4 e)ch!"+e tr!"s$(sio"is "ee#e# to #il(te bloo#6

    hy&o+lycemi! -B@ m+D#l1/ I +l(cose6

    8) 1=$ (macrosomia1/ !bo9e 0th &erce"tile

  • 8/19/2019 Semifinals 1

    38/354

    8) 1=$ (macrosomia1/ !bo9e 0th &erce"tile#(e to o9er&ro#(ctio" o$ +rowth hormo"e i"(tero- a!ove

  • 8/19/2019 Semifinals 1

    39/354

  • 8/19/2019 Semifinals 1

    40/354

  • 8/19/2019 Semifinals 1

    41/354

    =ICP #(e to l!r+e he!# c!" c!(se &ress(re

  • 8/19/2019 Semifinals 1

    42/354

      =ICP #(e to l!r+e he!# c!" c!(se &ress(reto res&ir!tory ce"ter6

      A #i!&hr!+m!tic &!r!lysis m!y occ(r

    bec!(se cer9ic!l "er9e tr!(m! !s the he!#is be"t si#ew!ys to !llow $or birth o$ l!r+esho(l#ers which &re9e"ts !cti9e l("+

    motio" o" !ecte# si#e6  Imme#i!te bre!st$ee#i"+ is "ee#e# to

    &re9e"t hy&o+lycemi!6

    1 &reterm nant less th!" 2 wee

  • 8/19/2019 Semifinals 1

    43/354

    1 &reterm nant less th!" 2 wee

  • 8/19/2019 Semifinals 1

    44/354

      Assessme"t

  • 8/19/2019 Semifinals 1

    45/354

    Assessme"t

    #is&ro&ortio"!te sie o$ he!# -= cm +re!terth!" chest sie14 r(##y s

  • 8/19/2019 Semifinals 1

    46/354

    1 Persistent patent ductus arteriosus #(e to&(lmo"!ry hy&erte"sio" which &re9e"tsclos(re o$ 'A6

    '6O6C6/ +buprofen or +ndomethacin -oli+(ri!1is +i9e" to close P'A6

    B1 Peri)entricular/ +ntra)enticular

    hemorrhage/ #(e to $r!+ile cerebr!lc!&ill!ries !"# imm!t(re cerebr!l 9!sc(l!r#e9elo&me"t% r(&t(re o$ c!&ill!ries le!# tohy#roce&h!l(s $rom blee#i"+ i"to the

    !5(e#(ct o$ Syl9i(s6

    @1 R'S4 !&"e!4 reti"o&!thy o$ &rem!t(rity

    100 ygen/c!" c!(se &(lmo"!ry e#em! or

    bli"#"ess o$ &rem!t(rity

      . mlDD

  • 8/19/2019 Semifinals 1

    47/354

    . mlDD

  • 8/19/2019 Semifinals 1

    48/354

    PostTerm I"$!"t bor" !$ter B8  wee

  • 8/19/2019 Semifinals 1

    49/354

      Res&ir!tory 'istress Sy"#rome -7M'1

  • 8/19/2019 Semifinals 1

    50/354

    Res&ir!tory 'istress Sy"#rome -7M'1

    Commo" i" &reterm i"$!"ts4 i"$!"ts o$

    #i!betic mothers4 those bor" thr( CS4 orthose with #ecre!se# bloo# &er$(sio" to thel("+s

    7y!li"e/ li

  • 8/19/2019 Semifinals 1

    51/354

    Assessme"t

    /'iKc(lty i"iti!ti"+ res&ir!tio"s !t birth%/low bo#y tem&

    /N!s!l ?!ri"+/ster"!l !"# s(bcost!l retr!ctio"s

    /t!chy&"e! = ;0 RR

    /cy!"otic m(co(s membr!"es

    /e)&ir!tory +r("ti"+ i" se9er!l ho(rs

    /sees!w res&ir!tio"s

    /7e!rt $!il(re show" by oli+(ri! !"# e#em! o$ e)tremities

    /P!le +r!y s

  • 8/19/2019 Semifinals 1

    52/354

    'i!+"osis o$ R'S +r("ti"+4 ce"tr!l cy!"osis i" room !ir4 t!chy&"e!4

    "!s!l ?!ri"+4 retr!ctio"s4 !"# shoc

  • 8/19/2019 Semifinals 1

    53/354

    1 &y&ancuronium( &avulon1% 9e"til!tory!ssist!"ce is (se# i" c!se o$ &ower $!il(re6

    @1 xtracorporeal mem!rane oxygenation-ECMO1

    bloo# is remo9e# $rom b!by by +r!9ity (si"+9e"o(s c!theter !#9!"ce# thr( ri+ht !tri(m

    !"# is o)y+e"!te# !"# rew!rme# !"# ret(r"e#thr( c!theter% (se# $or B/2 #!ys6

    ;1 1iEuid ventilation/ (se o$ &er?(oroc!rbo"s

    21 -itric oxide/ &(lmo"!ry 9!so#il!tio"i"cre!ses bloo# ?ow

  • 8/19/2019 Semifinals 1

    54/354

      econium $spiration /yndrome

  • 8/19/2019 Semifinals 1

    55/354

    p y

    /&rese"t i" !s e!rly !s .0 wee

  • 8/19/2019 Semifinals 1

    56/354

    / low APGAR4 #iKc(lty i" st!rti"+ res&ir!tio"s4

    t!chy&"e!4 retr!ctio"s4 !"# cy!"osis occ(r6

    / /$:4 s(ctio" i"$!"t with b(lb syri"+e !t&eri"e(m4 be$ore birth o$ sho(l#ers4 to !9oi#

    meco"i(m !s&ir!tio"6/#o "ot +i9e O8 by m!s< to &re9e"t &l(++i"+!l9eoli with meco"i(m

    /!ir tr!&&i"+ m!y c!(se b!rrel chest

    /Chest r!#io+r!&h will show bil!ter!l co!rsei">ltr!tes

    /#i!&hr!+m is &(she# #ow"w!r#s

      herapeutic 3anagement 

  • 8/19/2019 Semifinals 1

    57/354

    p g

    .1 Am"ioi"$(sio" to #il(te meco"i(m i" !m"iotic?(i#

    81CS1A"tibiotics

    B1 S(r$!ct!"t

    @1Obser9e $or !ir tr!&&i"+4 r(&t(re o$ !l9eoli c!"c!(se &"e(mothor!) - rele!se o$ !ir i"to&le(r!l s&!ce1

    ;1Chest &hysiother!&y with cl!&&i"+ !"#

    9ibr!tio" to e"co(r!+e remo9!l o$ meco"i(mrem"!"ts

  • 8/19/2019 Semifinals 1

    58/354

      SU''EN INFANT 'EAT7 SYN'ROME

  • 8/19/2019 Semifinals 1

    59/354

    &e!< i"ci#e"ce is 8/B mo"ths o$ !+e

    Commo" i" i"$!"ts o$ !#olesce"tmomsDclosely/ s&!ce# &re+"!"cies4 !"#("#erwei+htD&reterm i"$!"ts% i"$!"ts withbro"cho&(lmo"!ry #ys&l!si!4 twi"s4 Es

  • 8/19/2019 Semifinals 1

    60/354

    + &

      'ecre!se# !ro(s!l res&o"ses

      Possible l!c< o$ s(r$!ct!"t i" !l9eoli

      Slee&i"+ i" room with "o mo9i"+ !irc(rre"ts- re/bre!thi"+ c!rbo" #io)i#e1

    i"$!"ts !&&e!r well/"o(rishe#4 #ies

    so("#lessly #(e to l!ry"+os&!sm4 some !re$o("# with 9omit(s or bloo#/?ec

  • 8/19/2019 Semifinals 1

    61/354

    slee& !ssessme"t #o"e withi" the >rst 8 wee

  • 8/19/2019 Semifinals 1

    62/354

    Risi"+ le9el o$ !"tibo#ies -I"#irect Coomb*s test1 #(ri"+&re+"!"cy

    Co">rme# by !"tibo#ies o" $et!l erythrocytes i" cor#bloo# -&ositi9e #irect Coomb*s test1

    Mother will !lw!ys be Rh-/1 !"# i"$!"t will be Rh -1

    Se9ere !"emi! will c!(se he&!tome+!ly !"#s&le"ome+ly

    E)treme e#em! c!(ses hy#ro&s $et!lis

     V!("#ice o" >rst 8B ho(rs o$ li$e

    ,re!st$e# b!bies will show more :!("#ice #(e to&re+"!"e#iol which i"ter$eres with co":(+!tio" o$i"#irect bilir(bi"

    Norm!l I,L i" cor# bloo#J 0/ m+D.00 ml

    =80 i" termD=.8 m+D.00 ml i" &retermJ br!i" #!m!+e

       Ther!&e(tic M!"!+eme"t

  • 8/19/2019 Semifinals 1

    63/354

    .1 E!rly $ee#i"+/ bowel elimi"!tio" o$ bilir(bi"

    81 Photother!&y/e)&os(re to li+ht c!(ses li9er to&rocess bilir(bi"% 5(!rt h!lo+e"4 cool white li+htor s&eci!l bl(e ?(oresce"t li+ht is &l!ce# .8/0 i"!bo9e b!ssi"et

    .0/.8 m+D#l i" 8B ho(rsJ le9el !t which t) is "ee#e#by term b!bies

    ,ri+ht +ree" stoolsJ #(e to e)cretio" o$ e)cessi9ebilir(bi" -(ri"e is #!r

  • 8/19/2019 Semifinals 1

    64/354

    'URING INFANCY.6 I"t(ss(sce&tio"

    86 F!il(re to Thri9e6 Colic

    B6  Trisomy 8.

    @6 Cle$t P!l!te

    ;6 Im&er$or!te A"(s26 7irschs&r("+*s 'ise!se

    6 S&i"! ,i>#!

    6 7y#roce&h!l(s

    .06 Otitis Me#i!

    ..6 Me"i"+itis

    .86 Febrile Sei(res

    .6 A(tismD A'7'

    4let 1ip and &alate -&62B;1

  • 8/19/2019 Semifinals 1

    65/354

    C#'t L/ $!il(re o$ the m!)ill!ry !"# me#i!""!s!l &rocesses to close betwee" wee

  • 8/19/2019 Semifinals 1

    66/354

    anagement

  • 8/19/2019 Semifinals 1

    67/354

    S(r+ery o" ! cle$t li& is #o"e o" the i"iti!lhos&it!l st!y or betwee" 8/.0 wee

  • 8/19/2019 Semifinals 1

    68/354

    O"e o$ the most commo" #e9elo&me"t!l#isor#ers o$ the "er9o(s system !t birth%

    E)cess !cc(m(l!tio" o$ CSF i" the 9e"tricles orthe s(b!r!ch"oi# s&!ce c!(si"+ e"l!r+eme"to$ the s

  • 8/19/2019 Semifinals 1

    69/354

    .1 A +rowi"+ t(mor

    81 Obstr(ctio" o$ the &!ss!+e o$ ?(i# i" the

    !5(e#(ct o$ Syl9i(s/ most commo" c!(se%i"$ectio"s li

  • 8/19/2019 Semifinals 1

    70/354

    $ssessment

  • 8/19/2019 Semifinals 1

    71/354

    Se&!r!te# s(t(re li"e4 &romi"e"t sc!l& 9ei"s4i"cre!se# he!# circ(m$ere"ce4 bossi"+ o$

    $orehe!#4 s("set eyes4 leth!r+y or irrit!bility4shrill cry4 hy&er!cti9e re?e)es4

     Tr!"sill(mi"!tio" re9e!ls ?(i# r!ther t!" soli#br!i"

    /igns o F 4&

    =&(lse4 res&ir!tio"s

    tem&er!t(re4 ,P/str!bism(s4 o&tic !tro&hy4 FTT

    me!s(re chil#*s he!# !t birth $or b!seli"e #!t!

    !"# !ssess !ll chil#re" ("#er 8 ye!rs $or he!#

    anagement

  • 8/19/2019 Semifinals 1

    72/354

    e!rly #etectio" to &re9e"t br!i" #!m!+e4motor !"# me"t!l #eterior!tio"6

    iamox (diuretic) i$ c!(se# byo9er&ro#(ctio" o$ ?(i#

    Remo9!l o$ t(mor i$ #(e to obstr(ctio"

    >entriculoperitoneal shuntto remo9e

    e)cess CSF $rom 9e"tricles !"# sh("t it to the&erito"e(m i"to the bo#y circ(l!tio"

    Assess $or W ICP !$ter s(r+ery% !ssess $or si+"s

    o$ i"$ectio" or me"i"+itis s(ch !s sti "ec< orm!r

  • 8/19/2019 Semifinals 1

    73/354

    /&-$ 2:$ -P6 2;@1

  • 8/19/2019 Semifinals 1

    74/354

    'i9i#e# s&i"e #(e to l!c< o$ $(sio" o$

    &osterior s(r$!ce o$ embryo i" e!rlyi"tr!(teri"e li$e6

    Occ(rs !s ! &oly+e"ic i"herit!"ce &!tter" or$olic !ci# #e>cie"cy6

    ;00 mc+ o$ $olic !ci# $or &re+"!"t wome" to&re9e"t S,6

    MSAFP is obt!i"e# !t wee< .@ o$ &re+"!"cy to

    r(le o(t S, i" the 8"# chil# Am"ioce"tesis is #o"e to !ssess AFP i"

    !m"iotic ?(i#

    0ypes o /pina 2iGda

  • 8/19/2019 Semifinals 1

    75/354

    .1 A"e"ce&h!ly/ !bse"ce o$ cerebr!l

    hemis&heres whe" (&&er e"# o$ "e(r!l t(be$!ils to close i" e!rly i"tr!(teri"e li$e% commo"breech &rese"t!tio"% m!y s(r9i9e ! $ew #!ys#(e to i"t!ct me#(ll!

    81 Microce&h!ly/ c!(se# by i"tr!(teri"ei"$ectio"s li

  • 8/19/2019 Semifinals 1

    76/354

    1 S&i"! bi>#! occ(lt! / occ(rs commo"ly !t the@th l b # .st l l l #i li

  • 8/19/2019 Semifinals 1

    77/354

    @th l(mb!r !"# .st s!cr!l le9el% #im&li"+ or!b"orm!l t($ts o$ h!ir4 #iscolore# s

  • 8/19/2019 Semifinals 1

    78/354

  • 8/19/2019 Semifinals 1

    79/354

    $ssessment ' i i # h $

  • 8/19/2019 Semifinals 1

    80/354

    'etectio" is #o"e thr( so"o+r!m4 $etosco&y4!m"ioce"tesis or MSAFP

    CS is #o"e to !9oi# &ress(re !"# i":(ry to thes&i"!l cor#

    Assess $or s&o"t!"eo(s mo9eme"t o$ lowere)tremities !"# bowel !"# bl!##er $("ctio"

    Norm!l chil# is (s(!lly #ry $or 8/ ho(rs % i"$!"twith S, 9oi#s co"ti"(!lly6

    See T!ble 826./ Motor $("ctio" !bility i"

    chil#re" with myelome"i"+ocele -T;/.8Jcom&lete ?!cci# &!r!lysis o$ the lowere)tremities4

  • 8/19/2019 Semifinals 1

    81/354

    For me"i"+ocele4 myelome"i"+ocele ore"ce&h!locele4 Imme#i!te s(r+ery -withi" 8B/

    B ho(rs A,1 to re&l!ce co"te"ts !"# close s

  • 8/19/2019 Semifinals 1

    82/354

    /strict(re o$ the !"(s% the lower bowel e"#s i" !

    bli"# &o(ch='etecte# by so"o+r!m% i"s&ectio" !t birth will

    re9e!l ! membr!"e >lle# with bl!c< meco"i(mc!" be see" &rotr(#i"+ $rom the !"(s

    =Also ob9io(s by the i"!bility to i"sert ! rect!lc!theter i"to the !"(s4 "o stool will be &!sse#

    =F!il(re to &!ss stools !$ter the >rst 8B ho(rs

    =Collect ! (ri"e s&ecime"4 &rese"ce o$meco"i(m me!"s th!t there mi+ht be ! recto/bl!##er >st(l!

    anagement A t i $ t # b l li t i$

  • 8/19/2019 Semifinals 1

    83/354

    A"!stomosis o$ se&!r!te# bowel li+!me"ts i$rect(m e"#s close to the &eri"e(m

    All re&!irs !re com&lic!te# by >st(l!s to thebl!##er or 9!+i"!

     Tem&or!ry colostomy is cre!te# $or e)te"si9ere&!irs4 >"!l re&!ir is #o"e whe" i"$!"t is ;/.8

    mo"ths N(rsi"+ ') Im&!ire# tiss(e i"te+rity !t rect(m

    RT s(r+ic!l i"cisio"

    O(tcome e9!l(!tio" i"cisio" li"e rem!i"s $reeo$ erythem! or #r!i"!+e ("til it he!ls by !bo(t#!y 2 !$ter s(r+ery

    Rect!l #il!t!tio" ./8) #!y to e"s(re &!te"cy o$

    rect!l s&hi"cter

    4ommon +ealth &ro!lems 0hat evelopuring nancy -& .1

  • 8/19/2019 Semifinals 1

    84/354

    uring nancy -&6 .1

    I"t(ss(sce&tio" I"9!+i"!tio" o$ o"e &ortio" o$ the i"testi"e i"to

    !"other4 (s(!lly i" the 8"# h!l$ o$ the >rst ye!r

    . ye!rJ i#io&!thic c!(se =. ye!r4 le!# &oi"t - Mec

  • 8/19/2019 Semifinals 1

    85/354

    Chil# s(##e"ly #r!ws (& le+s !"# cry !s i$ i"

    se9ere &!i"4 m!y 9omit% &!i" s(bsi#es !"# thechil# &l!ys !+!i"% sym&toms rec(rs !$ter!ro("# .@ mi"(tes% 9omit(s will co"t!i" bile%c(rr!"t :elly li

  • 8/19/2019 Semifinals 1

    86/354

    S(r+ic!l emer+e"cy to &re9e"t "ecrosis

    I"still!tio" o$ w!ter/ sol(ble4 sol(tio"4 b!ri(me"em!4 or !ir i"to bowel

    Obser9e# !$ter 8B ho(rs $or rec(rre"ce%

    s(r+ery is #o"e $or !##itio"!l re#(ctio"

    7irschs&r("+* 'ise!se -A+!"+lio"icMe+!colo"1

  • 8/19/2019 Semifinals 1

    87/354

    Me+!colo"1

    Abse"ce o$ +!"+lio"ic i""er9!tio" to the m(scles o$ !sectio" o$ the bowel/ lower &!rt o$ si+moi# colo" :(st!bo9e the !"(s% "o &erist!ltic w!9es6

    Chro"ic co"sti&!tio" !"# ribbo"/ li

  • 8/19/2019 Semifinals 1

    88/354

     Two/st!+e s(r+ery

     Tem&or!ry colostomy the" bowel re&!ir !t .8/. mo"ths

    Perm!"e"t colostomy i$ chil# h!s "o !"!l "er9ee"#i"+s6

    COLIC &6

  • 8/19/2019 Semifinals 1

    89/354

    P!ro)ysm!l !b#omi"!l &!i" i" i"$!"ts ("#er

    ye!rs !"# is m!r

  • 8/19/2019 Semifinals 1

    90/354

    = !s< &!re"ts !bo(t #(r!tio" !"# $re5(e"cy

    = !s< wh!t h!&&e"s be$ore colic occ(rs

    ='oc(me"t "(mber !"# ty&e o$ bowelmo9eme"t

    =!ssess $ee#i"+ &!tter" -bre!stDbottle $e#1

    =!ssess m!ter"!l #iet -+!s/ $ormi"+ $oo#s1M!"!+eme"t

    =$ee# the b!by (&ri+ht

    =(se bottles with #is&os!ble b!+

    =t!

  • 8/19/2019 Semifinals 1

    91/354

    Most $re5(e"tly occ(rri"+ chromosom!l!b"orm!lity

    Co+"iti9ely/ ch!lle"+e#% I6 o$ @0/20 Pro$o("#ly !ecte# chil#re"*s I6 is less th!"

    80

    7e!# sie is sm!ller th!" the .0/80th &erce"tileo$ ! "orm!l chil#

    Altere# imm("e $("ctio"4 &ro"e to URTI

    Atrio9e"tric(l!r #e$ects4 #(o#e"!l ste"osis or

    !tresi!4 str!bism(s !"# c!t!r!ct #isor#ers !re!lso commo"

    ALL is 80 3 more commo" i" these chil#re"

    Li$es&!" is o"ly @0/;0 ye!rs4 $!ster !+i"+

    Assessme"t

  • 8/19/2019 Semifinals 1

    92/354

    =bro!#4 ?!t "ose% e)tr! e&ic!"th!l $ol#4

    &!l&ebr!l >ss(re sl!"ts l!ter!lly (&w!r#4,r(sh>el#*s s&ots4 &rotr(#i"+ to"+(e4 ?!t b!c<o$ the he!#4 short "ec"+ers with little >"+er c(r9e#i"w!r#% wi#e s&!ce betwee" >rstDseco"#>"+ers !"# toes4 simi!" cre!se

    M!"!+eme"t E"rolme"t i" e!rly e#(c!tio"!l !"# &l!y

  • 8/19/2019 Semifinals 1

    93/354

    E"rolme"t i" e!rly e#(c!tio"!l !"# &l!y&ro+r!ms

    7!"#w!shi"+ to #ecre!se i"$ectio"s Fee# slowly to &re9e"t cho

  • 8/19/2019 Semifinals 1

    94/354

    FE,RILE SEIZURES

    = most commo"ly see" i" &reschool chil#re" -@

  • 8/19/2019 Semifinals 1

    95/354

    = most commo"ly see" i" &reschool chil#re" -@

    mos/@ yrs1 or !s e!rly !s mo"ths to 2 ye!rs

    =$e9er !s hi+h !s .0B/ .0B*F=sei(res show !" !cti9e to"ic/ clo"ic &!tter"which l!st $or .@/80 seco"#s or ./8 mi"(tes

    = !ssess $or me"i"+itis

    Pre9e"tio"

    =

  • 8/19/2019 Semifinals 1

    96/354

    /s&o"+e with te&i# w!ter !$ter !" e&iso#e

    /#o "ot +i9e !cet!mi"o&he" &ost/ict!l to

    &re9e"t !s&ir!tio"/l(mb!r &("ct(re to r(le o(t me"i"+itis

    /!"ti&yretic #r(+s to re#(ce $e9er

    /!"tibiotics to tre!t i"$ectio"

    OTITIS ME'IA

  • 8/19/2019 Semifinals 1

    97/354

    = i"?!mm!tio" o$ the mi##le e!r4 most

    commo" #ise!se o$ chil#hoo# !$ter RTI= occ(rs !t ;/; mo"ths !"# !+!i" !t !+eB/; o$ !+e

    = commo" i" Al!s

    Assessme"t Occ(rs !$ter ! res&ir!tory tr!ct i"$ectio"

  • 8/19/2019 Semifinals 1

    98/354

      Occ(rs !$ter ! res&ir!tory tr!ct i"$ectio"

      Chil# h!s ! col#4 rhi"itis4 !"# low +r!#e

    $e9er $or ! $ew #!ys  S(##e" $e9er o$ .08*F !"# sh!r& co"st!"t

    e!r!che

      Stre& or 76 i"?(e"!  Irrit!bility4 &(lli"+ o$ !ecte# e!r

     Ther!&e(tic M!"!+eme"t

     A"!l+esicsD !"ti&yretics

      N!s!l #eco"+est!"ts $or #!ys o"ly

      Ce&h!los&ori"s $or &ersiste"t i"$ectio"

    :ailure to 0hrive I"$!"t $!lls below @th &erce"tile $or wei+ht

  • 8/19/2019 Semifinals 1

    99/354

    I"$!"t $!lls below @th &erce"tile $or wei+ht!"# hei+ht

    CAUSES.1 or+!"ic/ c!(se# by #ise!ses

    81 No"/ or+!"ic/ #ist(rbe# &!re"t/ chil#

    rel!tio"shi&% m!ter"!l role i"s(Kcie"cy%i"$!"t is &hysic!lly !"# emotio"!lly#e&ri9e#

    t!

  • 8/19/2019 Semifinals 1

    100/354

    leth!r+y with &oor m(scle to"e4 loss o$ sc $!t or s

  • 8/19/2019 Semifinals 1

    101/354

    M!rcits !"# i"ter$ere"ce withmet!bolism

    I"$!"t is &(t o" ! #iet ri+ht $or their i#e!l wei+ht% r!&i#wei+ht +!i" is #i!+"ostic o$ "o"or+!"ic $!il(re to thri9e

    $00-0O- :40 +&'$40>0/O''

  • 8/19/2019 Semifinals 1

    102/354

    /O''

    / persistent pattern of inattention and/or hyperacti)ity-

    impulsi)eness re)ealed before 9 years and occursmore fre:uently in boys

    6elated to child neglect, lead poisoning, and drugeposure in utero

    ; 3a disorgani?ation, repetition,

    compulsion

    81 !ri!bility/ loses t!s

  • 8/19/2019 Semifinals 1

    103/354

    1 Se5(e"ci"+/ &rocess o$ rel!ti"+ thi"+s to o"e !"otheri" time or s&!ce% #iKc(lty $ollowi"+ #irectio"s

    B1 Se5(e"ci"+ o$ wor#s/ #iKc(lty o$ (si"+ co":("ctio"s!"# &re&ositio"s

    @1 So$t "e(rolo+ic si+"s/ i"!bility to hol# ! &e"cil%i"!bility to reco+"ie ! sh!&e tr!ce# o" the s

  • 8/19/2019 Semifinals 1

    104/354

    .1 St!ble e"9iro"me"t $ree o$ stim(li/ &!stel colors4

    ro(ti"e81 Gi9e ste&/by/ste& i"str(ctio"s

    1 P("ishme"t sho(l# $ollow !" oe"se 5(ic

  • 8/19/2019 Semifinals 1

    105/354

    M!rcits i" l!"+(!+e4

    &erce&t(!l4 !"# motor #e9elo&me"t% #e$ecti9ere!lity testi"+% i"!bility to $("ctio" i" soci!lsetti"+s6

    L!c< o$ res&o"si9e"ess to other &eo&le4 +ross

    im&!irme"t i" comm("ic!tio" s

  • 8/19/2019 Semifinals 1

    106/354

    F!il(re to #e9elo& soci!l rel!tio"s

      Stereoty&e# beh!9ior s(ch !s h!"# +est(res

      E)treme resist!"ce to ch!"+e i" ro(ti"e  Ab"orm!l res&o"ses to se"sory stim(li

      'ecre!se# se"siti9ity to &!i"

     

    I"!&&ro&ri!te or #ecre!se# emotio"!le)&ressio"s

      S&eci>c4 limite# i"tellect(!l &roblem/ sol9i"+!bilities

      Im&!ire# !bility to i"iti!te or s(st!i" !co"9ers!tio"

    +$10+ &'O21/ 4OO- -0O1'/D

  • 8/19/2019 Semifinals 1

    107/354

    .6 CERE,RAL PALSY -&6.B@186 ,URNS -&6 .@;;1

    6 POISONING -&6 .@@1

    B6 C7IL' A,USE -&6.;1@6 MENINGITIS

    4'2'$1 &$1/D

  • 8/19/2019 Semifinals 1

    108/354

    "o"/ &ro+ressi9e (&&er motor "e(ro"

    im&!irme"t th!t res(lts i" motor #ys$("ctio"4s&eechD oc(l!r &roblems4 sei(res4 co+"iti9ech!lle"+es or hy&er!cti9ity4 m(scle s&!sticity

    CAUSES:

    I"tr!(teri"e !"o)i!J Lbw4 &l!ce"t!l #e$ects4"(tritio"!l #e>cie"cies4 #r(+s4 !"# m!ter"!li"$ectio"s -CMD to)o&l!smosis1

    Commo" i" L,HD SGA i"$!"ts !"# thosebor" i" OP &ositio"s

    Chil# !b(se4 S,S4 tr!(m! or se9ere

    #ehy#r!tio" me"i"+itis or e"ce&h!litis

    0&/D*. /pastic type e)cessi9e4 hy&erto"ic

  • 8/19/2019 Semifinals 1

    109/354

    *. /pastic type e)cessi9e4 hy&erto"icm(scles4 !b"orm!l clo"(s4 e)!++er!tio" o$

    'TRs4 !b"orm!l re?e)es -,!bi"s

  • 8/19/2019 Semifinals 1

    110/354

    ;) $taxic !w

  • 8/19/2019 Semifinals 1

    111/354

    & & &to/toe4 Romber+*s test4 resti"+ tremors4

    >"+er/to/"ose test4 heel/to/shi" test1

  • 8/19/2019 Semifinals 1

    112/354

      Ris< $or imb!l!"ce# "(tritio"4 less th!"bo#y re5(ireme"ts4 RT #iKc(lty i" s(c

  • 8/19/2019 Semifinals 1

    113/354

    I":(ries c!(se# by e)cessi9e he!t +re!terth!" .0B*F -B0*C16

    8"# c!(se o$ ("i"te"tio"!l i":(ry i" chil#re"./B yDo

    r# c!(se i" chil#re" @/.B yDo

    $ssessmentD

    HWhere and what is the extent and

    depth7I !s< the c!(se4 seco"#!ry he!lth &roblems4!s< !bo(t other chil#re"

  • 8/19/2019 Semifinals 1

    114/354

  • 8/19/2019 Semifinals 1

    115/354

  • 8/19/2019 Semifinals 1

    116/354

    *st egree !&&ly ice to cools

  • 8/19/2019 Semifinals 1

    117/354

    oi"tme"t !"# ! +!(e

    b!"#!+e

    8nd egree #o "ot r(&t(reblisters4 co9er with sil9ers(l$!#i!i"e !"# +!(e

    ;rd egree ?(i# ther!&y4

    systemic !"tibiotics4 &!i"m!"!+eme"t4 !"# &hysic!lther!&y

    -ursing iagnoses Ris< $or i"eecti9e bre!thi"+ &!tter"s RT to

  • 8/19/2019 Semifinals 1

    118/354

    + &res&ir!tory e#em! $rom b(r" i":(ry -RR

    rem!i"s withi" .;/80 b&m4 l("+!(sc(lt!tio" re9e!ls "o r!les1

    Ris< $or i"eecti9e tiss(e &er$(sio" RTc!r#io9!sc(l!r !#:(stme"ts !$ter b(r" i":(ry-chil#*s S st!ys withi" "orm!l limits% ho(rly(ri"e o(t&(t rem!i"s +re!ter th!" . mlD

  • 8/19/2019 Semifinals 1

    119/354

    + ycle!"i"+ !+e"ts4 cosmetics4 OTC #r(+s%

    s(s&ect s(ici#e !ttem&t i" !" ol#er chil#

    -ursing iagnosis Ris< $or i":(ry RT

    m!t(r!tio"!l !+e o$ chil# !"# &rese"ce o$&oiso"s -&!re"ts i#e"ti$y &oiso"o(s !"#to)ic items !t home !"# #escribe s!$estor!+e% st!tes loc!l &oiso" co"trol "(mber%

    #escribes me!s(res to see< hel&imme#i!tely1

  • 8/19/2019 Semifinals 1

    120/354

    $cetaminophen &oisoning= (se# to tre!t chil#hoo# $e9ers% c!(ses

  • 8/19/2019 Semifinals 1

    121/354

    !"ore)i!4 N4 :!("#ice4 te"#er li9er4

    ele9!te# li9er e"ymes !s l!r+e #oses c!"c!(se li9er #estr(ctio"

    = Acetylcystei"e -!cti9!te# ch!rco!l1 bi"#swith the bre!

  • 8/19/2019 Semifinals 1

    122/354

    my Ne+lect - "ot $e#4 clothe#4 s(&er9ise#

    &ro&erly4 "ot oere# me#ic!l c!re ore#(c!tio"!l o&&ort("ities1

    Psycholo+ic!l or emotio"!l - chil# is m!#e

    to $eel ("i"telli+e"t or i"!#e5(!te1  A+&s# "h#n !#:

    More !"+ry4 "o"com&li!"t4 !"# hy&er!cti9e

    Show &oor sel$/co"trol4 low sel$/ esteem More with#r!w" !"# h!9e ! ?!tter !ect

    7!9e ("#i!+"ose# me#ic!l &roblems-!"emi!4 otitis me#i!4 le!# &oiso"i"+4 ST's

  • 8/19/2019 Semifinals 1

    123/354

  • 8/19/2019 Semifinals 1

    124/354

    0+O'/ O: 4+1 $23/D.6 A &!re"t h!s the &ote"ti!l to !b(se the

  • 8/19/2019 Semifinals 1

    125/354

    chil# -s&eci!l &!re"t1% .03 h!9e ! h) o$

    me"t!l ill"ess% "o s(&&ort &erso"s% !b(se#!s chil#re"% isol!te#4 !lcoholic

    86 A chil# is see" !s #iere"t i" some w!yby the &!re"t -s&eci!l chil#1%m!y h!9e birth#e$ects4 m!y !ss(me role re9ers!l

    6 A" e9e"t or circ(mst!"ce bri"+s !bo(t the!b(se -s&eci!l circ(mst!"ce1% stress $rom

    wor

  • 8/19/2019 Semifinals 1

    126/354

    &e"!lty or loss o$ "(rsi"+ lice"se

    .1 st!te re5(ires hos&it!l to hol# the chil#$or 28 ho(rs% #etermi"!tio" is #o"e by co(rtwhether chil# is rele!se# to &!re"ts*c(sto#y or

  • 8/19/2019 Semifinals 1

    127/354

    &lot hei+ht !"# wei+ht i" ! +rowth ch!rt

    81 Ab(se# chil#re" h!9e hi+her i"ci#e"ces o$h!"# i":(ries% #ors!l h!"# b(r"s or sc!l#s!re commo"% ci+!rette b(r"s he!l withsc!rri"+% h(m!" bite m!r

  • 8/19/2019 Semifinals 1

    128/354

    mo"ths o$ !+e

    I" the U6S64 &e!< i"ci#e"ce is !t wi"ter #(eto Stre& &"e(mo"i!e or +ro(&/ , stre&

    I" chil#re" yo("+er th!" 8 mo"ths4 c!(se#

    by G, stre& or E6 Coli C!(se# by b!cteri!4 9ir(s thro(+h !" URTIor #irect i"tro#(ctio" thro(+h ! l(mb!r&("ct(re or s

  • 8/19/2019 Semifinals 1

    129/354

    +l!"# c!(si"+ e#em!

    $////-0

    8/ #!ys o$ URTI4 i"cre!si"+ly irrit!bility #(e

    to he!#!ches4 sh!r& &!i" o" be"#i"+ theirhe!# $orw!r#

    -1 Qer"i+*sD,r(#i"s

  • 8/19/2019 Semifinals 1

    130/354

    9ir(s4 !"# e"tero9ir(s

  • 8/19/2019 Semifinals 1

    131/354

    +

  • 8/19/2019 Semifinals 1

    132/354

    +

  • 8/19/2019 Semifinals 1

    133/354

  • 8/19/2019 Semifinals 1

    134/354

  • 8/19/2019 Semifinals 1

    135/354

    -ew!orn $ssessmentD/ Poor s(c

  • 8/19/2019 Semifinals 1

    136/354

    shoc

  • 8/19/2019 Semifinals 1

    137/354

    81 I"tr!thec!l !"tibiotics to &!ss thro(+h the bloo#/

    br!i" b!rrier

    1 Am&icilli"/ '6O6C $or =. inuen?ae

    4  Ce$ot!)imeD ce$tri!)o"e/ /.0 #!ys

    @1 Corticosteroi#s or m!""itol to re#(ce ICP !"#

    hel& &re9e"t he!ri"+ loss;1 Res&ir!tory &rec!(tio"s $or 8B ho(rs to !$ter

    !"tibiotic ther!&y is st!rte# to &re9e"ttr!"smissio"

    21 Pro&hyl!ctic !"tibiotics $or $!mily members

    1 Positio" +e"tly4 me!s(re he!# circ(m$ere"ce%chec< I !"# sDs o$ ICP4 wei+h% chec< SG o$ (ri"e

    7EALT7 PRO,LEMS COMMON INPRESC7OOLERS

  • 8/19/2019 Semifinals 1

    138/354

    .6 LEUQEMIA -&6.@B186 HILM*S TUMOR

    6 AST7MA

    B6 UTI

  • 8/19/2019 Semifinals 1

    139/354

    13J$ (p. *59

  • 8/19/2019 Semifinals 1

    140/354

    4$3//D radiation exposure to chemicals, genetics ncreased incidence in twins, those withown :anconi syndromesL exposure to

    radiation/&0O/D-/tarts with pallor, lowgrade ever, anemia,!leeding a!normalities, easy !ruising

    -/plenomegaly and hepatomegaly causesa!dominal pain, vomiting, and anorexia

  • 8/19/2019 Semifinals 1

    141/354

    invasion o lymphocytes invade !oneperiosteum causing !one and Moint pain4-/ invasion leads to headache orunsteady gait

    &ainless swelling o su!maxillary andcervical nodeslevated leu%ocytes, low platelets andhematocrit !ut normal '24

    0/0/D*. 2one marrow aspiration at the iliac crestD

    (N) 85K !last cells1um!ar tapD presence o !last cells in

  • 8/19/2019 Semifinals 1

    142/354

    isease 4lassiGcationD*. 2 1ymphocytes cell typesD @5K (4$11$PNQ)

    8. t 1ymphocytes cell typesD*58AK

    0+'$&304 $-$=-0D*. nduction phaseD complete remission or

    a!sence o leu%emia cells * month tx with vincristine prednisone,

    1 asparaginase, doxoru!icin through acentral venous port (nonirritating)Lallopurinol (:)

  • 8/19/2019 Semifinals 1

    143/354

    8. 4onsolidation or /anctuary phaseDintrathecal administration omethotrexate or oral

    6mercaptopurine to prevent leu%emic

    cells to #ourish in the 4-/ P222Q(less usedtoday due to / o minimal learningdisorders)

    ;. elayed ntensive therapyD intensiGeddosage >&1a,o,4yclophosphamide,cytosine ara!inoside ($'$4) or 6thioguanine

  • 8/19/2019 Semifinals 1

    144/354

  • 8/19/2019 Semifinals 1

    145/354

    do not give oral and intrathecalmethotrexate at the same time

    Ommaya reservoirD silicon tu!ing inserted

    into cere!ral ventricle and threaded underthe scalp to chec% 4/: or samplingL nomore repeated lum!ar punctures

  • 8/19/2019 Semifinals 1

    146/354

  • 8/19/2019 Semifinals 1

    147/354

    Jidney involvementD can limit the use o

    chemotx0esticular invasionD invasion o testes !yleu%emic cells can cause sterilityL sperm!an%ing !eore therapy is started i patientis past pu!ertyN&sn D/: 'is% or inection '0 nonunctioning W24s and immunosuppresive

    efects o therapyO&t"om# E0!&!tonD 4hild"s temperatureremains lower than [email protected]":(;?"4)L no areaso erythema or drainage present on s%in

  • 8/19/2019 Semifinals 1

    148/354

    N&sn D/ D 'is% or deGcient #uid volume'0 increased chance o hemorrhage rompoor platelet production

    O&t"om# #0!&!ton: -O evidence ohemorrhage at present (no epistaxis,hematuria, or hematemesis), &', '' W-1or age group

  • 8/19/2019 Semifinals 1

    149/354

    8. $cute yeloid 1eu%emia ($1)Dprolieration o granulocytes (neu, !aso,and eo) seen in 8AK

    in late adolescence

    same symptoms with $11L increasedsuscepti!ility to 3'0 !eore dxgmt.D*. nduction phaseD4ytara!ine and

    aunoru!icin or *8 months or ullremission

  • 8/19/2019 Semifinals 1

    150/354

    8. 4onsolidationsanctuaryD 4yclo and 6thioguanine or 69 months

    2one marrow transplant to ensure new

    growth o normal granulocytes

    SSremission is more diTcult with $1

    4O-=-0$1 +$'0 /$/ (4+)D

    C7's !re str(ct(r!l #e$ects o$ the he!rt4

  • 8/19/2019 Semifinals 1

    151/354

    4+re!t 9essels4 or both th!t !re &rese"t $rom

    birth/ 8"# o"ly to &rem!t(rity !s ! c!(se o$ #e!th i"the >rst ye!r o$ li$e

    Cli"ic!l Cl!ssi>c!tio" o$ Co"+e"it!l he!rt #ise!se

    1. cyanotic P'A4 AS'4 S'

    2. (yanotic TOF4 TG4 Tr("c(s !rterios(s;. bstructi)e Co!rct!tio" o$ Aort!4 AS4 PS

    ACYANOTIC CHD (PDA)1. PATENT DUCTUS ARTERIOSUS (PDA)•results when the fetal ductus arteriosus fails to

  • 8/19/2019 Semifinals 1

    152/354

    close completely after birth

    Pathophysiology:

    •blood flows from the aorta through the PDA andback to the pulmonary artery and lungs, causing >LV workload and pulmonary vascular congestion

    41-4$1 $-:/0$0O-/D=i$ #e$ect is sm!ll4 chil# m!y be !ysm&tom!tic! lo(# m!chi"e li

  • 8/19/2019 Semifinals 1

    153/354

    •child may have CHF with poor feeding, fatigue,hepatosplenomegaly, poor weight gain,tachypnea and irritability, widened pulse

    db d l b

  • 8/19/2019 Semifinals 1

    154/354

    pressure and bounding pulse rate maybe

    detected

    1$2O'$0O' $- $=-O/04 :--=/ECG "orm!l b(t m!y show 9e"tricle

    e"l!r+eme"t i$ the sh("t is l!r+eN(rsi"+ m!"!+eme"t.6 Pro9i#e $!mily te!chi"+ !bt6 tre!tme"t o&tio"ssome close s&o"t% others c!" be close# s(r+ic!llyor "o"/s(r+ic!lly86 I" &rem!t(re i"$!"ts4 P'A c!" be close# (si"+&rost!+l!"#i" sy"thet!se i"hibitors

    -I"#ometh!ci"1 wDc stim(l!te clos(re o$ the

    an a!normal communication !etween theatriaL results when the atrial septal tissuedoes not use properly during em!ryonicd t

  • 8/19/2019 Semifinals 1

    155/354

    devt.

    &athophysiologyD

    •pressure is higher in the let atrium than

    the right, causing !lood to shunt rom letto right•the '> and &$ enlarge !ecause they arehandling more !lood$ssessment GndingsD*. most inants tend to !e aysmptomaticuntil early childhood and many deects

    close spont !y 5 yo

  • 8/19/2019 Semifinals 1

    156/354

    Laboratory and diagnostic findings:

    •ECG – normal but may show ventricle enlargement if the shunt is large

    2. slow weight gain and frequent respiratoryinfections may occur3. systolic ejection murmur may be auscultated,

  • 8/19/2019 Semifinals 1

    157/354

    LABORATORY AND DIAGNOSTIC STUDYFINDINGS:

    1. Echocardiography with Doppler gen. reveals the

    enlarged R side of the heart and the inc.pulmonary circulation2. Cardiac catheterization demonstrates theseparation of the R atrial septum and the inc.

    oxygen saturation in the R atrium

    y j yusually most prominent at the 2nd ICS

    Nursing Management:1. Provide family teaching abt. treatment options:

  • 8/19/2019 Semifinals 1

    158/354

    y g pa. defects are usually repaired in girls due to

    possibility of clot formation during child bearingyearsb. small ASDs are left open in boys, larger ones arerepairedc. surgical closure is performed during the schoolage years

    C. VENTRICULAR SEPTAL DEFECT- the most common CHD where there is anabnormal opening between the right and left

  • 8/19/2019 Semifinals 1

    159/354

    ventricles

    - the degree of this defect vary from a pinholebetween the R & L ventricles to an absentseptumPathophysiology:

    •pressure from the LV causes blood to flowthrough the defect to RV, resulting in increasedpulmonary vascular resistance and right heartenlargement•'> and &$ pressures increase, leadingeventually to o!structive pulmonaryvascular disease

  • 8/19/2019 Semifinals 1

    160/354

    Assessment findings:1.symptoms vary with the size of the defect, age andamtofresistance,usuallythechildis

  • 8/19/2019 Semifinals 1

    161/354

    amt of resistance, usually the child isasymptomatic.2. failure to thrive, excessive sweating, fatigue3. more susceptible to pulmonary infections4. may exhibit s/s of CHF

    1a!oratory and diagnostic study Gndings

    .6 Echoc!r#io+r!&hy with 'o&&ler UDS or MRI

    re9e!ls R7 !"# &ossible PA #il!t!tio" $rom thei"c6 bloo# ?owECG shows R7

    NURSING MANAGEMENT:

  • 8/19/2019 Semifinals 1

    162/354

    1. provide family teaching about treatment options

    2. some VSDs close spontaneously3. others are closed with a Dacron patch,recommended for large defects, PA hypertension,

    CHF, recurrent resp. infxns. FTT

    4$-O04 4+00'$1O= O: :$11O0 (0O:)

    co"sists o$ B m!:or !"om!lies

  • 8/19/2019 Semifinals 1

    163/354

    / co"sists o$ B m!:or !"om!lies

    !6 S' c6 PSb6 R7 #6 o9erri#i"+ !ort!

    &athophysiology

    •PS im&e#es the ?ow o$ bloo# to the l("+s4c!(si"+ i"cre!se# &ress(re i" the R4 $orci"+#eo)y+e"!te# bloo# thro(+h the se&t!l #e$ect tothe L

    •the i"cre!se# wor

  • 8/19/2019 Semifinals 1

    164/354

    of the VSD and the degree of PS.

    1. Acute episodes of cyanosis (“tet spells”) andtransient cerebral ischemia;“Tet spells” are char.by irritability, pallor, and blackouts or

    convulsions.2. Cyanosis at rest (as PS worsens)3. Squatting (a char. posture of older children thatserves to decrease the return of poorly

    oxygenated venous blood from the lowerextremities and to inc. SVR, w/c increasespulmonary blood flow and eases respiratory effort)

    4. slow weight gain5. clubbing, exertional dyspnea, fainting, or fatigueslownessduetohypoxia

  • 8/19/2019 Semifinals 1

    165/354

    slowness due to hypoxia

    6. a pansystolic murmur may be heard at the mid-lower left sternal border

    LABORATORY AND DIAGNOSTIC STUDY

    FINDINGS1. echocardiography and ECG show the enlargedchambers of the right side of the heart2. echocardiography also demonstrates the

    decrease in the size of the PA and the reducedblood flow through the lungs

    3. cardiac catheterization and angiography allowdefinitive evaluation of the extent of the defect,particularlythePSandtheVSD

  • 8/19/2019 Semifinals 1

    166/354

    particularly the PS and the VSD

    4. CBC reveals polycythemia, ABG demonstratereduced oxygen saturation

    NURSING MANAGEMENT:

    1. Provide family teaching about treatment options elective repair is usually performed during theinfant’s 1st year of life, but palliative repairs maybe warranted for infants who cannot undergo

    primary repairtotal repair involvesVSD closure,infundibular stenosis resection, and pericardial

    patch to enlarge RV outflow tract2. Provide preoperative and postoperative care

    B. TRANSPOSITION OF GREAT VESSELS (TGV)-inTGV,thePAleavestheLVandtheaorta

  • 8/19/2019 Semifinals 1

    167/354

    in TGV, the PA leaves the LV and the aorta

    exits the RV, there is no communication betweenthe systemic and pulmonary circulationsPathophysiology•this defect results in two separate circulatory

    patterns; the right heart manages systemiccirculation and the left manages pulmonarycirculation to sustain life, the child must have anassociated defect.

    - Associated defects such as septal defects or aPDA, permit oxygenated blood into the systemiccirculation but cause increased cardiac workload.

  • 8/19/2019 Semifinals 1

    168/354

    -POTENTIAL COMPLICATIONS : CHF, infective endocarditis, brain abscess, and

    cerebralvascularaccidentsresulting from

  • 8/19/2019 Semifinals 1

    169/354

    cerebral vascular accidents resulting from

    hypoxia or thrombosis.ASSESSMENT FINDINGS:Clinical manifestations vary, depending onassociated defects

    1. In infants with minimal communication (noassociated defects), severe respiratory depressionand cyanosis, will be evident at birth

    2. In infants with associated defects, there is lesscyanosis but the infant may have symptoms ofCHF,easily fatigued, FTT

    LABORATORY AND DIAGNOSTIC STUDYFINDINGS1echocardiographyrevealsanenlargedheart

  • 8/19/2019 Semifinals 1

    170/354

    1. echocardiography reveals an enlarged heart

    2. cardiac catheterization reveals low O2 saturationresulting from the mixing of blood in the chambers

    NURSING MANAGEMENT

    1. Provide family teaching about the treatmentoptions2. Prostaglandin E is administered to maintain aPDA and further blood mixing.

    3. An arterial switch procedure within the 1st weekof life is the surgical procedure of choice

    C. TRUNCUS ARTERIOSUS- failure of normal septation and division of theembryonic bulbar trunk into the PA and aorta,

    lti i i l ltht id bth

  • 8/19/2019 Semifinals 1

    171/354

    resulting in a single vessel that overrides both

    ventriclesPathophysiology•blood ejected from the ventricles enters thecommon artery and flows either the lungs or aortic

    arch.pressure in both ventricles is high and blood flowto the lungs is markedly increased.

    Assessment findings:1. neonates with this defect appear normal;however, as pulmonary vascular resistancedecreases after birth, severe pulmonary edema and

    CHFcommonldevelo

  • 8/19/2019 Semifinals 1

    172/354

    2. marked cyanosis, especially on exertion; S/Sof CHF; LVH, dyspnea, marked activity intolerance,d t dd th

  • 8/19/2019 Semifinals 1

    173/354

    and retarded growth

    > loud systolic murmur best heard at the lowerleft sternal border and radiating throughout thechestLaboratory and diagnostic study findings:1. echocardiography reveals the defectNURSING MANAGEMENT1. surgical repair is necessary in the 1st few

    months of life, the mortality rate associated withsurgery is greater than 10%; w/o surgery, childrendie w/in 1 yr.

     COARCTATION OF AORTA (COA)•a defect that involves a localizednarrowingoftheaorta

  • 8/19/2019 Semifinals 1

    174/354

    narrowing of the aorta

    Pathophysiology•COA is char. by inc. pressure proximalto the defect and decreased pressuredistal to it

    restricted blood flow through thenarrowed aorta increases the pressureon the LV and causes dilation of theproximal aorta and LVH, w/c may lead

    to LVF•eventually, collateral vessels developto bypass the coarctated segment andsupply circulation to the LE

     Assessment findings:Clinical manifestations1. the child may be asymptomatic or mayexperiencetheclassicdifferenceinBP

  • 8/19/2019 Semifinals 1

    175/354

    experience the classic difference in BP

    and pulse quality between the upper andlower ext. – the BP is elevated in the UEand dec. in the LE while the pulse is bounding in the UE and dec. or absent

    in the LE. Thus femoral pulse are weakor absent2. epistaxis, headaches, fainting andlower leg cramps3. a systolic murmur may be heard overthe left anterior chest and between thescapula posteriorly; rib notching may be

    observedinanolderchild

  • 8/19/2019 Semifinals 1

    176/354

    Laboratory and dagnostcfindings:

    1. ECG, echocardiography, andchestx-raymayrevealleftsided

  • 8/19/2019 Semifinals 1

    177/354

    chest xray may reveal left sided

    heart enlargement resulting from back pressurethe radiograph may alsodemonstrate rib notching from

    enlarged collateral vesselsNursing management:1. repair involves surgical removal ofthe stenotic area

    2. nonsurgical repair via balloonangioplasty

    Aortic

    2. $O'04 /0-O// ($/)-! #e$ect th!t &rim!rily i"9ol9es !"b t ti t th L t? $ th l

  • 8/19/2019 Semifinals 1

    178/354

    obstr(ctio" to the L o(t?ow o$ the 9!l9e

    &$0+O&+/O1O=D

    •L &ress(re i"c6 to o9ercome resist!"ce o$the obstr(cte# 9!l9e !"# !llow bloo# to?ow i"to the !ort!4 e9e"t(!lly &ro#(ci"+

    L7•MI m!y #e9elo& !s the i"c6 O8 #em!"#s o$the hy&ertro&hie# L +o ("met

    ASSESSMENT FINDINGS:CLINICALMANIFESTATIONS:

  • 8/19/2019 Semifinals 1

    179/354

    CLINICAL MANIFESTATIONS:

    1. faint pulse, hypotension, tachycardia, andpoor feeding pattern

    2. exercise intolerance, chest pain, anddizziness when standing for long periods3. a systolic ejection murmur may be heardbest at the 2nd ICS

    LABORATORY AND DIAGNOSTIC STUDYFINDINGS:

  • 8/19/2019 Semifinals 1

    180/354

    1. ECG or echocardiography reveals LVH2. cardiac catheterization demonstratesdegree of the stenosisNURSING MANAGEMENT:1. if the child’s symptoms warrant, surgicalaortic valvulotomy or prosthetic valvereplacement is necessary;

    balloon angioplasty can be used to dilate thenarrow valve

  • 8/19/2019 Semifinals 1

    181/354

    C. PULMONIC STENOSIS (PS)-a defect that involves obstruction of bloodflow from the right ventricleh h il

  • 8/19/2019 Semifinals 1

    182/354

    Pathophysiology:•RV pressure increases leading to RVH andeventually RV failure may occur Assessment findings:

    Clinical manifestations1. may be asymptomatic or may have mildcyanosis or CHF2. a systolic murmur may be heard over the

    pulmonic area; a thrill may be heard ifstenosis is severe;decreased exercisetolerance, dyspnea, precordial pain andgeneralized cyanosis may occur

    LABORATORY AND DIAGNOSTICFINDINGS:1. ECG or echocardiography reveals RVH2cardiaccatheterizationdemonstratesthe

  • 8/19/2019 Semifinals 1

    183/354

    2. cardiac catheterization demonstrates the

    degree of stenosisNURSING MANAGEMENT:1. provide family teaching about treatmentoptions2. Balloon angioplasty techniques are being widely used to treat PS3. Surgical valvulotomy may be performed

    (although the need for surgery isuncommon due to the widespread use of balloon angioplasty techniques)4. provide preoperative and postoperative

  • 8/19/2019 Semifinals 1

    184/354

    RHEUMATIC HEART FEVER•Aninflammatoryautoimmunedisease

  • 8/19/2019 Semifinals 1

    185/354

    • An inflammatory autoimmune disease

    that affects the connective tissues of theheart, joints, subcutaneous tissues, and blood vessels of the central nervoussystem

    •Rheumatic heart disease is the mostserious complication•

    Presents 2-6 weeks following anuntreated or partially treated Group A beta-hemolytic streptococcal infection ofthe upper respiratory tract

  • 8/19/2019 Semifinals 1

    186/354

     Assessment:1. Fever: low grade fever that spikes in thelate afternoon2. Elevated antistreptolysin O titer

    3. Elevated sedimentation rate4. Elevated C-reactive protein5. Aschoff bodies (lesions): Found in theheart, blood vessels, brain and seroussurfaces of the joints and pleura6. Leukocytosis

  • 8/19/2019 Semifinals 1

    187/354

    Ascho*s bo#ies

    INTERVENTIONS :•Assess vital signs•Control joint pain and inflammation with massageand alternating hot and cold applications as prescribed

    d bd d fb l h

  • 8/19/2019 Semifinals 1

    188/354

    •Provide bed rest during acute febrile phase•Limit physical exercise in the child with carditis•Administer antibiotic (Penicillin) as prescribed•Administer salicylates and anti-inflammatory agents(prednisone) as prescribed

    •Initiate seizure precautions if the child is experiencingchorea•Instruct the parents about the importance of follow-upand the need for antibiotic prophylaxis for dental work,

    infection and invasive procedures•Instruct child to inform parents of strep infxns inschool

    SEIZURE DISORDERS

  • 8/19/2019 Semifinals 1

    189/354

    Assessment:>Obtain information from the parents about thetime of onset, precipitating events, and behaviorand after seizure

    >Determine the child’s history related to seizures Aura, Apnea, cyanosisPost-seizure: Disoriented, sleepyAbsence seizures: Occur in children between 4 to

    12 years of age, last 5 to 10 seconds, and the childappears inattentive

    Interventions:•Ensure airway patency

  • 8/19/2019 Semifinals 1

    190/354

    Have suction equipment and oxygen available•Time the seizure episode•Ease the child down to floor, placing the child in aside-lying position (standing or sitting)

    •Place a pillow or folded blanket under the child’shead; if no bedding is available, place your ownhands under the child’s head or place the child’shead in your lap

    •Loosen restrictive clothing

    •Remove eyeglasses from the child if present•Cleartheareaofanyhazardsorhardobjects

  • 8/19/2019 Semifinals 1

    191/354

    •Clear the area of any hazards or hard objects

    •Allow the seizure to proceed and end withoutinterference•If vomiting occurs, turn the child to one side asone unit•Do not restrain the child, place anything in thechild’s mouth, or give any food or liquids to thechild•Prepare to administer medication as ordered

    DRUGS: ANTICONVULSANTDepress abnormal neuronal discharges and

    prevent the spread of seizures to adjacent neurons

  • 8/19/2019 Semifinals 1

    192/354

    >Hydantoins: Ethotoin (Peganone), Fosphenytoin(Cerebyx), Phenytoin (Dilantin)

    >Barbiturates: Phenobarbital; alcohol (Luminal),Amobarbital ( Amytal), Mephobarbital ( Mebaral)>Benzodiazepines: Clonazepam (Klonopin),Diazepam (Valium), Lorazepam (Ativan)

    Nsg. Interventions:•Iitit i ti

  • 8/19/2019 Semifinals 1

    193/354

    •Initiate seizure precautions•Monitor urinary output•Monitor liver and renal function tests andmedication blood serum•

    Monitor for signs of toxicity: CNS depression,ataxia, N & V, drowsiness, dizziness, restlessnessand visual disturbances•Remain with the child until he/she fully recovers

    •Observe for incontinence, which may haveoccurred during the seizure•Document occurrence

    •Sezure Precautons:a. Raise the side rails when the child is sleeping orrestingb. Pad the side rails and other hard objects

  • 8/19/2019 Semifinals 1

    194/354

    c. Place a waterproof mattress or pad, on the bedor cribd. Instruct the child to wear or carry medicalcertification

    e. Instruct the child in precautions to take duringpotentially hazardous activities.f. Instruct the child to swim with a companiong. Instruct the child to use a protective helmet and

    padding when engaged in bicycle riding,skateboarding, and in-line skatingh. Alert caregivers to the need for any specialprecautions

    ATTENTION DEFICIT HYPERACTIVITYDISORDER (ADHD)

    -Developmentaldisordercharacterizedby

  • 8/19/2019 Semifinals 1

    195/354

    Developmental disorder characterized by

    inappropriate degrees of inattention, over-activity,and impulsivity- Childhood problems include lowered intellectualdevelopment, some minor physical abnormalities,

    sleeping disturbances, behavioral or emotionaldisorders- Diagnosis is established based on self-reports,parent and teacher reports, and psychologicalassessments

    Assessment:•Fidgets with hands or feet or squirms in the seat

  • 8/19/2019 Semifinals 1

    196/354

    Easily distracted with external or internal stimuli•Assessment:•Difficulty with following through on instructions•Poor attention span•Shifting from one uncompleted activity to another•Talking excessively•Interrupting or intruding on others•Engaging in physically dangerous activities

    without considering the possible consequences

    Interventions:•Provide environmental and physical safetymeasures

  • 8/19/2019 Semifinals 1

    197/354

    measures•Enhance capabilities and self-esteem•Encourage support groups for parents•Administer prescribed medication;

    Methylphenidate hydrochloride (Ritalin), pemoline(Cylert), and dextroamphetamine

    SICKLE CELL ANEMIADescriptionThisconstitutesagroupofdiseasestermed

  • 8/19/2019 Semifinals 1

    198/354

    - This constitutes a group of diseases termed

    hemoglobinopathies, in which hemoglobin A ispartly or completely replaced by abnormal sicklehemoglobin S.- It is caused by the inheritance of a gene for astructurally abnormal portion of the hemoglobinchain.-Hemoglobin Sis insensitive to changes in the

    oxygen content of the red blood cell.- Insufficient oxygen causes the cells to assume asickle shape and the cells become rigid andclumped together, obstructing capillary blood flow 

    SITUATIONS THAT PRECIPITATE SICKLING-emotional or physical stress; any condition thatincreases the need for oxygen or alters the

  • 8/19/2019 Semifinals 1

    199/354

    transport of oxygen can result in sickle cell crisis(acute exacerbation).RISK FACTORS:> parents heterozygous for hemoglobin S or

     being African American descent. > reversible under conditions of adequateoxygenation and hydration; after repeated sickling,the cell becomes permanently sickled.

     > The clinical manifestations primarily occur asa result of obstruction caused by sickled red bloodcells and increased red blood cell destruction.

    - Sickle cell crises are acute exacerbations ofthe disease, which vary considerably in

  • 8/19/2019 Semifinals 1

    200/354

    severity and frequency; these include vaso-occlusive crisis, splenic sequestration, andaplastic crisis.Care focuses on the prevention (preventing

    exposure to infection and maintaining normalhydration) and treatment (oxygen, hydration,pain management, and bed rest) of the crisis.

    INTERVENTIONS:1. Maintain adequate hydration and blood flowwith intravenously administered normal saline asprescribed,andwithoralfluids.

  • 8/19/2019 Semifinals 1

    201/354

    prescribed, and with oral fluids.

    2. Administer oxygen and blood transfusions asprescribed to increase tissue perfusion.3. Administer analgesics as prescribed (round theclock); administration of meperidine (Demerol) isavoided because of the risk of normeperidine-induced seizures.4. Assist the child to assume a comfortable

    position so that the child keeps the extremitiesextended to promote venous return; elevate thehead of the bed no more than 30 degrees, avoidputting strain or painful joints, and do not raise

    th k th fth bd

    anagementSt!rt !"!l+esics &rom&tly to &ro9i#e eecti9e relie$ o$&!i"6

  • 8/19/2019 Semifinals 1

    202/354

    ild painP!r!cet!mol -80m+D

  • 8/19/2019 Semifinals 1

    203/354

    + +

    Some &!tie"ts m!y re5(ire hi+her i"#i9i#(!l#oses4 b!se# o" &rior history or m!y be"e>t$rom co"ti"(o(s i"$(sio" 9i! PCA -P!tie"tCo"trolle# A"!l+esi!16

    M!y "ee# bloo# tr!"s$(sio" (si"+ H,C >ltere#bloo#

    &aracetamol80 m+D

  • 8/19/2019 Semifinals 1

    204/354

    ib(&ro$e" 86@ .0 m+Drst to see eect4the" re&e!t !t @ / .0 mi"(te i"ter9!ls !s re5(ire# (& tom!)im(m tot!l #ose16R#s!to$ ##sson s / re#(ce #oses i$combi"e# with se#!ti9es6 M!y +et #el!ye# res&ir!tory#e&ressio" !$ter tre!ti"+ c!(se o$ &!i"6

    5. Encourage consumption of a high-calorie, high-protein diet, with folic acid supplementation.6. Administer antibiotics as prescribed to preventinfection.

  • 8/19/2019 Semifinals 1

    205/354

    7. Monitor for signs of complications, includingincreasing anemia, decreased perfusion, and shock(mental status changes, pallor, vital sign changes).8. Instruct the child and parents about the early

    signs and symptoms of crisis and the measures toprevent crisis.9. Ensure that the child receives pneumococcal,Haemophilus influenza type B, and meningococcalvaccines because of the susceptibility to infectionfrom functional asplenia.10. Inform the parents of the hereditary aspects of

    th di d

    APLASTIC ANEMIA:- This is a deficiency of circulating erythrocytesand all other formed elements of blood, resulting

  • 8/19/2019 Semifinals 1

    206/354

    from the arrested development of cells within thebone marrow.CAUSES :chronic exposure to myelotoxic agents, viruses,

    infection, autoimmune disorders, and allergicstates.- The definitive diagnosis is determined by bonemarrow aspiration (demonstrates conversion of redbone marrow to fatty red bone marrow).

    -Therapeutic management:-restoring function to the bone marrow andinvolves immunosuppressive therapy and bonemarrowtransplantation(treatmentofchoiceifa

  • 8/19/2019 Semifinals 1

    207/354

    marrow transplantation (treatment of choice if a

    suitable donor exists).

    -If the cause is myelotoxic medication that is beingadministered for another purpose, the medicationmay be discontinued to improve bone marrowfunction.

    ASSESSMENT:1.Pancytopenia:

  • 8/19/2019 Semifinals 1

    208/354

    planned.

    •Administer immunosuppressive medications as prescribed;antilymphocyte globulin or antithymocyte clobulin may beprescribed to suppress the autoimmune response.•Colo"y/stim(l!ti"+ $!ctors m!y be &rescribe# to e"h!"ce

    bo"e m!rrow &ro#(ctio"6•Corticosteroi#s !"# cyclos&ori"e m!y be &rescribe#6•Gi9e ,T i$ &rescribe# !"# HOF tr!"s$(sio" re!ctio"s•Mo"itor $or si+"s RT #ise!se !"# to t)•A#9ice &!re"ts to obt!i" ! Me#ic/ Alert br!celet $or thechil#

  • 8/19/2019 Semifinals 1

    209/354

    HEMOPHILIA

    - Refers to a group of bleeding disorders resulting

  • 8/19/2019 Semifinals 1

    210/354

    from a deficiency of specific coagulation proteins.- Identifying the specific coagulation deficiency isimportant so that definitive treatment with thespecific replacement agent can be implemented;

    aggressive replacement therapy is initiated toprevent the chronic crippling effects from jointbleeding.

    TYPES:1.Factor VIII deficiency (hemophilia A or classichemophilia)

    2.Factor IX deficiency (hemophilia B or Christmas disease

  • 8/19/2019 Semifinals 1

    211/354

    - Hemophilia is transmitted as an X-linked recessivedisorder (it may also occur as a result of a gene mutation).- It is most frequently transmitted by the union of anunaffected male with a trait-carrier female; however, it canresult from the union between an affected male and anormal female or a carrier female, leading to offspring suchas an affected son, affected daughter, carrier daughter, ornormal son.TREATMENT:

    •. replacement of the missing clotting factor;•. pain meds may be prescribed depending on the source ofbleeding from the disorder.

    ASSESSMENT•Abnormal bleeding in response to trauma orsurgery (sometimes is detected after circumcision)•Epistaxis(nosebleeds)

  • 8/19/2019 Semifinals 1

    212/354

    Epistaxis (nosebleeds)•Joint bleeding causing pain, tenderness, swelling,and limited range of motion•Tendency to bruise easily•

    Results of tests that measure platelet function arenormal; results of tests that measure clotting factorfunction may be abnormal.

    INTERVENTIONS:•Monitor for bleeding and maintain bleedingprecautions.

  • 8/19/2019 Semifinals 1

    213/354

    •Prepare/ administer replacement factors asprescribed.•Monitor for joint pain; immobilize the affectedextremity if joint pain occurs.

    •Assess neurological status (child is at risk forintracranial hemorrhage).•Monitor urine for hematuria.•Control joint bleeding by RICE(15 minutes) forsuperficial bleeding.

    •Instruct the child and parents about the signs ofinternal bleeding.•Instruct the parents in how to control thebleeding.

  • 8/19/2019 Semifinals 1

    214/354

    bleeding.

    •Instruct the parents regarding activities for thechild, emphasizing the avoidance of contact sportsand the need for protective devices while learningto walk.•Instruct the child to wear protective devices suchas helmets and knee and elbow pads whenparticipating in sports such as bicycling and

    skating.Instruct the parents to obtain a Medic-Alertbracelet or medallion

    VON WILLEBRAND DISEASE:

  • 8/19/2019 Semifinals 1

    215/354

    - A hereditary bleeding disorder characterized by adeficiency of or a defect in a protein termedvonWillebrand factor(vWF)- The disorder causes platelets to adhere to

    damaged endothelium; the vWF protein also servesas a carrier protein for factor VIII.- It is characterized by an increased tendency tobleed from mucous membranes.

    ASSESSMENT•Epistaxis•Gum bleeding•Easy bruising

  • 8/19/2019 Semifinals 1

    216/354

    y g

    •Excessive menstrual bleeding

     INTERVENTIONS•Treatment and care are similar to those measuresimplemented for hemophilia, including theadministration of clotting factors.•Provide emotional support to the child and

    parents, especially if the child is experiencing anepisode of bleeding.

    β-THALASSEMIA MAJOR

    -Autosomal recessive disorder characterized by the

  • 8/19/2019 Semifinals 1

    217/354

    reduced production of one of the globin chains inthe synthesis of hemoglobin (both parents must becarriers to produce a child with β-thalassemiamajor).

    - The incidence is highest in individuals ofMediterranean descent, such as Italians, Greeks,

    Syrians, or their offspring.

    -TREATMENT:-supportive; the goal of therapy is to maintainnormalhemoglobinlevelsbytheadministrationof

  • 8/19/2019 Semifinals 1

    218/354

    normal hemoglobin levels by the administration ofblood transfusions.- A splenectomy may be performed in a child withsevere splenomegaly who requires repeated

    transfusion (assists in relieving abdominalpressure and may increase the life span ofsupplemental red blood cells).

    ASSESSMENT•Frontal bossing•Maxillary prominence

  • 8/19/2019 Semifinals 1

    219/354

    •Wide-set eyes with a flattened nose•Greenish-yellow skin tone•Hepatosplenomegaly•Severe anemia

    •Microcytic, hypochromic red blood cells

    INTERVENTIONS•Administer blood transfusions as prescribed;monitor for transfusion reactions.

  • 8/19/2019 Semifinals 1

    220/354

    •Monitor for iron overload,; chelation therapy withdeferoxamine (Desferal) may be prescribed totreat iron overload and to prevent organ damagefrom the elevated levels of iron caused by the

    multiple transfusion therapy.•If the child has had a splenectomy, instruct theparents to report any signs of infection because ofthe risk of sepsis.•Provide genetic counseling.

     HEMOLYTIC-UREMIC SYNDROME (HUS) >bacterial toxins, chemicals, and viruses that cause acuterenal failure in children.infants and small children between the ages of 6 months

  • 8/19/2019 Semifinals 1

    221/354

    and 5 years.

    3 CLINICAL FEATURES OF THE DISEASE1. acquired hemolytic anemia/ thrombocytopenia

    2. renal injury,3. central nervous system symptoms.ASSESSMENT•Triad of anemia, thrombocytopenia, and renal failure isdiagnostic

    •Proteinuria, hematuria, and presence of urinary casts•Blood urea nitrogen and serum creatinine levels areelevated; hemoglobin and hematocrit levels are decreased

    •Hemodialysis or peritoneal dialysis may be prescribed ifthe child is anuric•Hemodialysis requires venous access (arteriovenous [AV]shunt, fistula, or graft) and treatment is usually 3 to 8hours in length (three times per week); peritoneal dialysis

  • 8/19/2019 Semifinals 1

    222/354

    INTERVENTIONS

    g ( p );p y

    requires surgical placement of an abdominal catheter

    •(correction of fluid and electrolyte imbalance is slower thanhemodialysis).

    •Dialysate solution is prescribed to meet the child’selectrolyte needs.• Strict monitoring of fluid balance is necessary; fluidrestrictions may be prescribed if the child is anuric.•Institute measures to prevent infection.•Provide adequate nutrition.

  • 8/19/2019 Semifinals 1

    223/354

    BLADDER EXSTROPHY- congenital anomaly characterized by extrusion

    oftheurinarybladdertotheoutsideofthebody

  • 8/19/2019 Semifinals 1

    224/354

    of the urinary bladder to the outside of the bodythrough a defect in the lower abdominal wall.-The cause is unknown.

    - Treatment requires surgical management andoccurs in a series of staged reconstructions.- Initial surgery for closure of the abdominal defectshould occur within thefirst few days of life.

    - The goal of subsequent operations is toreconstruct the bladder and genitalia and enablethe child to achieve urinary continence.

    Assessment•Exposed bladder mucosa•Widened symphysis pubis•Defects of the external genitalia

  • 8/19/2019 Semifinals 1

    225/354

    INTERVENTIONS:•Monitor urinary output.•Monitor for signs of urinary tract or woundinfection.•

  • 8/19/2019 Semifinals 1

    226/354

    •Maintain the integrity of the exposed bladdermucosa.•Prevent the bladder tissue from drying, whileallowing the drainage of urine, until surgical

    closure is performed.•The bladder is covered with sterile, non-adherentclear plastic wrap or a sterile thin film dressingwithout adhesive.

    •Petroleum jelly is avoided because it tends to dryout, adhere to the bladder mucosa, and damagethe delicate tissues when the dressing is removed.

    •Monitor laboratory values and urinalysis to assessfor renal function.•Administer antibiotics as prescribed.•Provide emotional support to the parents, and

  • 8/19/2019 Semifinals 1

    227/354

    encourage verbalization of their fears andconcerns.

    NEPHROBLASTOMA (WILM’S TUMOR)-Most common intra-abdominal and kidney tumorof childhood; it may present unilaterally and

  • 8/19/2019 Semifinals 1

    228/354

    localized or bilaterally, sometimes with metastasisto other organs- Peak incidence is at 3 years of age-The occurrence is associated with a genetic

    inheritance and with several congenital anomalies- - Therapeutic management includes a combinedtreatment of surgery (partial or total nephrectomy)and chemotherapy with or without radiation,depending on the clinical stage and histologicalpattern of tumor

     ASSESSMENT•Swelling or mass in the abdomen (mass ischaracteristically firm, non-tender,

  • 8/19/2019 Semifinals 1

    229/354

    confined to one side, deep within the flank• Abdominal pain•Urinary retention or hematuria• Anemia•Pallor, anorexia, lethargy•Hypertension• Weight loss and fever•Sxs. Of lung involvement:

    •Dyspnea•Shortness of breath•Pain in the chest

  • 8/19/2019 Semifinals 1

    230/354

  • 8/19/2019 Semifinals 1

    231/354

    Pre-operative Interventions•Monitor v/s particularly bp•Avoid palpation of the abdomen•Place a sign at the bedside, “Do not palpate

  • 8/19/2019 Semifinals 1

    232/354

    abdomen”•Measure abdominal girth at least once daily

    Post-operative Interventions

    •Monitor temperature and blood pressure closely•Monitor for signs of hemorrhage and infection•Monitor strict I & O closely•Monitor for abdominal distention, monitor bowel

    sounds, and other signs of GI activity (risk forobstruction)

    CYSTIC FIBROSIS (CF)-chronic multisystem disorder (autosomal recessivetrait disorder) characterized by exocrine glanddysfunction.

  • 8/19/2019 Semifinals 1

    233/354

    - The mucus produced by the exocrine glands isabnormally thick, tenacious, and copious, causingobstruction of the affected organs, particularly inthe respiratory, gastrointestinal, and reproductivesystems.- The most common symptoms are pancreaticenzyme deficiencycaused by duct blockage,

    progressive chroniclung disease associated withinfection, andsweat gland dysfunction resulting inincreased sodiumand chloride sweatconcentrations.

    r

    most reliable diagnostic test, the sweat chloride test

    - CF is a fatal genetic disorder and respiratory failure is themost common cause of death.RESPIRATORY SYSTEM:Symptoms are produced by the stagnation of mucus in the

  • 8/19/2019 Semifinals 1

    234/354

    airway, leading to bacterial colonization and destruction oflung tissue.Emphysema and atelectasis occur in the airways becomeincreasingly obstructed.Chronic hypoxemia causes contraction and hypertrophy ofthe muscle fibers in pulmonary arteries and arterioles,leading to pulmonary hypertension and eventual corpulmonale.Pneumothorax from ruptured bullae and hemoptysis from

    erosion of the bronchial wall occur as the diseaseprogresses.

    OTHER RESPIRATORY SYMPTOMS:Wheezing and dry nonproductive cough,dyspnea, c yanosisclubbing of the fingers and toes,barrel chest, r epeatedepisodes of bronchitis and pneumonia

  • 8/19/2019 Semifinals 1

    235/354

    Gastrointestinal systems:Meconium ileus in the neonate Intestinal obstruction (distal intestinal obstructive

    syndrome) caused by thick intestinal secretions;signs include pain, abdominal distention, nausea,and vomiting.Steatorrhea (frothy, foul-smelling stools)

    Deficiency of thefat-soluble vitamins A, D, E, andK, which causeseasy bruising and anemiaMalnutrition andfailure to thrive

    Demonstration of hypoalbuminemia fromdiminished absorption of protein, resulting ingeneralized edemaRectal prolapse that can result from the large,

  • 8/19/2019 Semifinals 1

    236/354

    gbulky stools and lack of supportive fat pads aroundthe rectumIntegumentary system

    Abdominally high concentrations of sodium andchloride in sweatParents reporting that the infant tastes “salty”when kissed

    Dehydration and electrolyte imbalances, especiallyduring hyperthermic conditionsReproductive systemCystic fibrosis can delay puberty in girls.

    Fertility can be inhibited by the highly viscous cervicalsecretions, which act at a plug and block sperm entry.Males are usually sterile, caused by the blockage of the vasdeferens by abnormal secretions or by failure of normal

  • 8/19/2019 Semifinals 1

    237/354

    y ydevelopment of duct structures.

    Diagnostic tests:Quantitative sweat chloride test: >60 mg (+);

  • 8/19/2019 Semifinals 1

    238/354

    •Chest physiotherapy(percussion and postural drainage)on awakening and in the evening (more frequently duringpulmonary infection); not done before or immediately after ameal

    •Bronchodilator medication by aerosol opens the bronchifor easier expectoration (administered before the chestphysiotherapy when the child has reactive airway disease oris wheezing).

    •Use of a Flutter Mucus Clearance Device(a small, hand-held plastic pipe with a stainless steel ball on the inside)that facilitates removal of mucus; store away from smallchildren because if the device separates, the steel ball posesa choking hazard.

  • 8/19/2019 Semifinals 1

    239/354

    •Use o a T AIRapy vest devcethat provide high-

    frequency chest wall oscillation to help loosen secretions.•Administering medications as prescribed to decrease theviscosity of mucus.•Instruct the parents not to give cough suppressants such

  • 8/19/2019 Semifinals 1

    240/354

    as guaifenesin (Robitussin) because they will inhibitexpectoration of secretions and promote infection.•Teach the child forced expiratory technique (huffing) tomobilize secretions.•Develop a physical exercise program with the aim of

    establishing an effective habitual breathing pattern.•Administer antibiotics as prescribed, which may beprescribed prophylactically or when pulmonary symptomsdevelop.

    •Aerosolized antibiotics may be prescribed and areadministered after chest physiotherapy is performed, orantibiotics may be prescribed and administeredintravenously at home through a central venous accessdevice.

    •Administer oxygen as prescribed during acuteepisodes; monitor closely foroxygen narcosis(signsinclude nausea and vomiting, malaise, fatigue,numbness and tingling of extremities, substernal

  • 8/19/2019 Semifinals 1

    241/354

    distress).•Monitor for hemoptysis;more than 300 mL in 24hours for the older child (less for a younger child)needs to be treated immediately.•Hemoptysis may be controlled by bed rest, coughsuppressants, antibiotics, and vitamin K; ifhemoptysis persists, the site of bleeding may be

    cauterized or embolized.•Lung transplantation is a final therapeutic optionfor the child with end-stage disorder.

    Gastrointestinal systemThe goal of treatment for pancreatic insufficiency is toreplace pancreatic enzymes; this is administered withall meals and all snacks to ensure that digestive

  • 8/19/2019 Semifinals 1

    242/354

    enzymes are mixed with food in the duodenum.•The amount of pancreatic enzymes administered isadjusted to achieve normal growth and a decrease inthe number of stools to two or three daily.

    •Enteric-coated pancreatic enzymes should not becrushed or chewed.•Pancreatic enzymes should not be given if the child isNPO.

    •Encourage a well-balanced, high-protein, high-caloride diet; multivitamins and vitamins A, D, E, andK are also administered.

    •Assess weight and monitor for failure to thrive.•Monitor for constipation and intestinal obstruction.•Ensure adequate salt intake and fluids that provide anadequate supply of electrolytes during extremely hotweather and if the child has a fever.

  • 8/19/2019 Semifinals 1

    243/354

    Home care•Instruct the child and family about the prescribedtreatment measures and their importance.

    •Instruct the parents and caregivers to be sureimmunizations are up to date.•Inform the parents and caregivers that the child should bevaccinated yearly for influenza; pneumococcus vaccine may

    also be prescribed.Inform the child and family about the Cystic FibrosisFoundation.

    wilm

    ASTHMA:- chronic inflammatory disease of the airwaysmarked by airway inflammation and

    hyperresponsiveness to a variety of stimuli or

  • 8/19/2019 Semifinals 1

    244/354

    triggers- Commonly caused by physical and chemicalirritants such as foods, pollens, dust mites,cockroaches, smoke, animal dander, temperature

    changes, respiratory infection, activity and stress- Mast cell release of histamine leads tobronchoconstrictive process- Common symptom is coughing in the absence of

    respiratory infection, especially at night

    STATUS ASTHMATICUS- Child displays respiratory distress despite vigoroustreatment measures; a medical emergency that can resultin respiratory failure and death if left untreated

  • 8/19/2019 Semifinals 1

    245/354

    Assessment:•episodes of wheezing, breathlessness, dyspnea, chesttightness, and cough particularly at night and or in theearly morning•Child may present with prodromal itching localized at the

    front of the neck or over the upper part of the back•Exacerbations are episodes of progressively worseningshortness of breath, cough, wheezing, chest tightness,decreases in expiratory airflow secondary to bronchospasm,

    mucosal edema, and mucous plugging; air is trappedbehind occluded or narrow airways and hypoxemia occurs

    •Asthmatic episode:•The episode begins with irritability, restlessness,headache, feeling tired, and or chest tightness•Respiratory symptoms include a hacking, irritable,

  • 8/19/2019 Semifinals 1

    246/354

    non-productive cough caused by bronchial edema•Accumulated secretions stimulate the cough;cough becomes rattling, and there is production of

    frothy, clear, gelatinous sputum•Retractions•Hyperresonance on percussion of the chest isnoted

    Breath sounds are coarse and loud, with crackles,coarse rhonchi, and inspiratory and expiratorywheezing; expiration is prolonged

    •Exercise-induced bronchospasm-cough,

    shortness of breath, chest pain or tightness,wheezing, and endurance problems occur duringexercise•Severe spasm or obstruction-breath sounds and

  • 8/19/2019 Semifinals 1

    247/354

    crackles may become inaudible, and the cough isineffective (lack of air movement)•Ventilatory failure and asphyxia- shortness of

    breath, with air movement in the chest restricted tothe point of absent breath sounds accompanied bya sudden rise in respiratory rate•Child may be pale or flushed, and the lips may

    have a deep, dark red color that may progress tocyanosis observed in the nail beds and skin,especially in the mouth

    •Restlessness apprehension and diaphoresis occur•Younger children assume tripod sitting position;older children sit upright with a shoulders in ahunched-over position, the hands on the bed or a

    hi dth b dtf ilittth f

  • 8/19/2019 Semifinals 1

    248/354

    chair, and the